Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04639128 · ClinicalTrials.gov registry record · NA
Adductor Canal Catheter Effectiveness and Safety Study
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 126
- Enrollment target
NCT04639128 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 126 participants.
The verdict
NCT04639128, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
Study Summary
PRIMARY OBJECTIVE: Compare the effect of usual care with an adductor canal catheter (ACC) containing ropivacaine to the effect of usual care without an ACC on the second-postoperative-day pain levels among patients undergoing elective primary unilateral total knee arthroplasty (TKA) SECONDARY OBJECTIVES: Among a sample of patients undergoing elective primary unilateral TKA who receive peri-articular anesthetic injections: 1. To compare the overall two-week levels of postoperative pain between those participants randomized to ACCs containing ropivacaine and those participants randomized to usual care without an ACC 2. To compare the use of opioid medications (in mean total morphine milligram equivalents) between those participants randomized to ACCs containing ropivacaine and those participants randomized to usual care without an ACC over the two-week postoperative period 3. To describe the incidence of complications related to ACC placement including infection, displacement, ACC-related clinic or emergency department (ED) visits 4. To conduct exploratory analyses to identify candidate predictors of differential response to the ACC
Interventions
- DEVICE Adductor Canal Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2023-01-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04639128
The ClinicalTrials.gov registry entry for NCT04639128 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adductor Canal Catheter is the first listed.
NCT04639128 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04639128 about?
NCT04639128 is a clinical study titled "Adductor Canal Catheter Effectiveness and Safety Study". PRIMARY OBJECTIVE: Compare the effect of usual care with an adductor canal catheter (ACC) containing ropivacaine to the effect of usual care without an ACC on the second-postoperative-day pain levels among patients undergoing elective primary unilateral total knee arthroplasty (TKA) SECONDARY OBJEC...
What is the current status of trial NCT04639128?
This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2021-03-15. Estimated completion is 2023-01-13.
What interventions are being tested in trial NCT04639128?
The interventions under investigation include: Adductor Canal Catheter (DEVICE).
Who is sponsoring clinical trial NCT04639128?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.